Report Overview
The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after the ingestion of a single 150-mg tablet.
Some women with recurrent candidal infections opt for treatment with over-the-counter (OTC) medications, which generally are highly effective for candidiasis. Preparations for intravaginal administration of butoconazole, clotrimazole, miconazole, and tioconazole are available OTC.
This report contains market size and forecasts of Drugs for Vulvovaginal Candidiasis in India, highlights the following information:
Sales of Drugs for Vulvovaginal Candidiasis in India: Value 2019 VS 2023 VS 2030, ($ millions)
Sales of Drugs for Vulvovaginal Candidiasis in India: Volume 2019 VS 2023 VS 2030, (K Units)
Sales of Drugs for Vulvovaginal Candidiasis in India: Revenue Market Share by Company, 2019-2024
Sales of Drugs for Vulvovaginal Candidiasis in India: Volume Market Share by Company, 2019-2024
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Drugs for Vulvovaginal Candidiasis will continue to grow rapidly in the future.
The global Drugs for Vulvovaginal Candidiasis market size was valued at 816.6 million in 2023 and is forecast to a readjusted size of US$ 907.4 million by 2030, with a CAGR of 1.5% during the forecast period 2024-2030.While the India Drugs for Vulvovaginal Candidiasis market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. India will account for % percent of Drugs for Vulvovaginal Candidiasis's global value in 2030, from % in 2023.
Our research team has surveyed the Drugs for Vulvovaginal Candidiasis manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, Value, demand, price change, product matrix, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
India Drugs for Vulvovaginal Candidiasis Market, By Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
India Drugs for Vulvovaginal Candidiasis Market Segment Percentages, By Type, 2023 (%)
Cream
Pessary
Other
India Drugs for Vulvovaginal Candidiasis Market, By Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
India Drugs for Vulvovaginal Candidiasis Market Segment Percentages, By Application, 2023 (%)
Hospital & Clinic
Pharmacy
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Vulvovaginal Candidiasis revenues in India market, 2019-2024 (Estimated), ($ millions)
Key companies Drugs for Vulvovaginal Candidiasis sales in India market, 2019-2024 (Estimated), (K Units)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Perrigo
J & J
Pfizer
Bristol-Myers Squibb
Effik
Teva
Sanofi
Cisen Pharmaceutical
Kingyork Group
Market Size Overview
USD Million
-
2026-
2032-
CAGR (2024-2032)MARKET SIZE 2026
USD - MN
Million
MARKET SIZE 2032
USD - MN
Million
CAGR (2026-2032)
-
FASTEST GROWING REGION
Asia Pacific
LARGEST MARKET
Asia Pacific
Key Market Segmentation
By Purity Level
- 4N
- 5N
- 6N
- Others
By Application
- Semiconductor
- Display
- Solar
- Others
By End-User Industry
- Electronics
- Optoelectronics
- Photovoltaics
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Regional Market Insights
Asia Pacific
China, Japan, South Korea, Southeast Asia, India
North America
U.S., Canada, Mexico
Europe
Germany, France, UK, Italy
South America
Brazil, etc.
Middle East and Africa
Turkey, GCC Countries, Africa, etc.
Global Perspective. Local Insight.
Our reports deliver comprehensive regional coverage to help you understand market dynamics, identify growth opportunities, and make informed decisions.
VALUE YOU CAN TRUST
Why Buy This Report?
Actionable insights. Trusted data. Smarter decisions.
Everything you need to stay ahead with confidence.
01
Gain a comprehensive understanding of the market
02
Make informed business decisions with data-backed insights
03
Identify growth opportunities and emerging markets
04
Stay ahead of competitors with actionable intelligence
05
Support strategic planning and investment decisions
06
Access detailed market segmentation and regional analysis
07
Benchmark key players, pricing, and market share
08
Benefit from reliable forecasts, trends, and future outlook
09
Understand customer demand, sales potential, and industry dynamics
10
Save research time with expert-validated data and analysis
Need Customization?
Reliable Reports
Trusted by Leaders
Global Coverage
100+ Countries
24/7 Support
We're Here to Help
Secure Payments
Safe & Trusted